EMCURE - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Technical Rating: 4.2

Here’s a concise but detailed technical analysis of Emcure Pharmaceuticals Ltd. (EMCURE) based on current indicators and price behavior

📉 Trend Overview

Price at ₹1,409 is above both 50 DMA (₹1,303) and 200 DMA (₹1,251)

This positions Emcure firmly in a short-term uptrend, with strong trend confirmation

Trend Status: Trending upward, but nearing overbought zone

📊 Momentum Indicators

RSI: 66.0 → closing in on overbought; buying strength present but cautious zone ahead

MACD: 34.0 → bullish crossover intact, signaling strong upward momentum

Volume: 86,888 vs avg 1.2L → mild dip in volume, but still supportive of bullishness

🌟 Together, these indicate continued strength, although near short-term exhaustion

📈 Moving Averages

DMA Value (₹) Interpretation

50 DMA 1,303 Confirmed support

200 DMA 1,251 Strong long-term base

Price trending above both → suggests bullish sentiment unless major reversal triggers

📎 Bollinger Bands

Price likely closer to upper band, consistent with bullish channel

Minor widening → trend continuation probable, but volatility may increase

No signs of band squeeze → breakout already in motion

🎯 Trade Zones

Zone Type Price Range (₹) Strategy

Entry Zone 1,340–1,380 Minor pullbacks can be buy-on-dip zones

Resistance 1,460–1,490 Next ceiling levels

Exit Target 1,500–1,580 Profit-taking zone near 52W high

Support Zone 1,300–1,325 Protective floor level

🔒 Suggested stop-loss: ₹1,290 for short-term trades

🧾 Fundamental & Institutional Signals

Qtr Profit ↑ 69.5%, EPS ₹36 → strong earnings push supporting rally

Stock P/E 38.8 vs Industry PE 34.0 → slightly stretched valuation

PEG Ratio 30.3 → indicates optimism priced in

ROE 18.6%, ROCE 20.8% → healthy return metrics

FII/DII holding ↓ → mild profit booking by institutions

🧭 Conclusion

Emcure is in a bullish trend, with indicators signaling further upside but caution near upper resistance levels. A short-term dip near ₹1,350–₹1,380 could be an ideal entry zone, especially if RSI stabilizes. Targeting ₹1,500–₹1,580 is reasonable unless volume sharply declines or bearish divergence forms.

Want help tracking it with price alerts, or comparing it to similar pharma plays like Alkem or Torrent?

Edit in a page